Eosinophils in asthma and other allergic diseases.
A hallmark of allergic disease is infiltration of the tissues with increased numbers of eosinophils. This is the result of the co-ordinated action of cytokines, particularly IL-5, CCR3 binding chemokines and the adhesion molecules P-selectin and VCAM-1, acting in concert to cause selective trafficki...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2000
|
| _version_ | 1826283581686677504 |
|---|---|
| author | Wardlaw, A Brightling, C Green, R Woltmann, G Pavord, I |
| author_facet | Wardlaw, A Brightling, C Green, R Woltmann, G Pavord, I |
| author_sort | Wardlaw, A |
| collection | OXFORD |
| description | A hallmark of allergic disease is infiltration of the tissues with increased numbers of eosinophils. This is the result of the co-ordinated action of cytokines, particularly IL-5, CCR3 binding chemokines and the adhesion molecules P-selectin and VCAM-1, acting in concert to cause selective trafficking of eosinophils into allergic tissue. This process is orchestrated by the Th-2 allergen specific lymphocyte. While there is little data to support the view that eosinophils ameliorate the allergic process, although they could have an important role in the disordered repair that leads to permanently impaired function in some allergic diseases, the evidence that they cause many of the pathophysiological features of allergic disease, while strong, remains circumstantial. Much of the data could be interpreted just as easily to suggest that eosinophils are bystander cells; markers of a certain type of pathological process, but not impinging upon it. The most direct evidence for a pathological role rests on the toxicity of the eosinophil granule proteins for bronchial epithelium and the bronchoconstrictor actions of the sulphidopeptide leukotrienes. The actions of LT antagonists in asthma which are certainly beneficial, but in most cases are not as effective as glucocorticoids, could be interpreted both for and against the eosinophil. In this paper we have focused on the studies that ask most directly the question of whether eosinophils are important effector cells in the pathogenesis of allergic disease. We conclude with a qualified affirmative. Even if they are only bystander cells they remain clinically important as diagnostic markers and a guide to the management of allergic disease. |
| first_indexed | 2024-03-07T01:01:01Z |
| format | Journal article |
| id | oxford-uuid:89b8937b-e304-4bda-a241-05a56d3b7691 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T01:01:01Z |
| publishDate | 2000 |
| record_format | dspace |
| spelling | oxford-uuid:89b8937b-e304-4bda-a241-05a56d3b76912022-03-26T22:26:36ZEosinophils in asthma and other allergic diseases.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:89b8937b-e304-4bda-a241-05a56d3b7691EnglishSymplectic Elements at Oxford2000Wardlaw, ABrightling, CGreen, RWoltmann, GPavord, IA hallmark of allergic disease is infiltration of the tissues with increased numbers of eosinophils. This is the result of the co-ordinated action of cytokines, particularly IL-5, CCR3 binding chemokines and the adhesion molecules P-selectin and VCAM-1, acting in concert to cause selective trafficking of eosinophils into allergic tissue. This process is orchestrated by the Th-2 allergen specific lymphocyte. While there is little data to support the view that eosinophils ameliorate the allergic process, although they could have an important role in the disordered repair that leads to permanently impaired function in some allergic diseases, the evidence that they cause many of the pathophysiological features of allergic disease, while strong, remains circumstantial. Much of the data could be interpreted just as easily to suggest that eosinophils are bystander cells; markers of a certain type of pathological process, but not impinging upon it. The most direct evidence for a pathological role rests on the toxicity of the eosinophil granule proteins for bronchial epithelium and the bronchoconstrictor actions of the sulphidopeptide leukotrienes. The actions of LT antagonists in asthma which are certainly beneficial, but in most cases are not as effective as glucocorticoids, could be interpreted both for and against the eosinophil. In this paper we have focused on the studies that ask most directly the question of whether eosinophils are important effector cells in the pathogenesis of allergic disease. We conclude with a qualified affirmative. Even if they are only bystander cells they remain clinically important as diagnostic markers and a guide to the management of allergic disease. |
| spellingShingle | Wardlaw, A Brightling, C Green, R Woltmann, G Pavord, I Eosinophils in asthma and other allergic diseases. |
| title | Eosinophils in asthma and other allergic diseases. |
| title_full | Eosinophils in asthma and other allergic diseases. |
| title_fullStr | Eosinophils in asthma and other allergic diseases. |
| title_full_unstemmed | Eosinophils in asthma and other allergic diseases. |
| title_short | Eosinophils in asthma and other allergic diseases. |
| title_sort | eosinophils in asthma and other allergic diseases |
| work_keys_str_mv | AT wardlawa eosinophilsinasthmaandotherallergicdiseases AT brightlingc eosinophilsinasthmaandotherallergicdiseases AT greenr eosinophilsinasthmaandotherallergicdiseases AT woltmanng eosinophilsinasthmaandotherallergicdiseases AT pavordi eosinophilsinasthmaandotherallergicdiseases |